Drug intelligence / Profile preview

Vasoclean

Development stage
Phase 4
Lead developer
Cho-A Pharm
Modality
Small Molecules
Administration
Oral
01

Overview

Vasoclean is an oral solution containing *Ginkgo biloba* leaf extract, developed and manufactured by the South Korean company Cho-A Pharmaceutical. Each 10ml dose typically contains 20mg of the extract, standardized to 4.8mg of ginkgo flavon glycosides. The medication is primarily used to enhance cerebral and peripheral blood circulation. It is indicated for the symptomatic treatment of cognitive impairment in the elderly, including memory loss and dementia, as well as for sensory conditions such as tinnitus and dizziness caused by cerebral ischemia. Additionally, it is used to treat peripheral arterial circulation disorders and retinal ischemia. The extract works by improving blood flow, inhibiting platelet-activating factor (PAF) receptors, and providing neuroprotective antioxidant effects.

Brand names
VasocleanVasoclean Sol
Other names
Ginkgo biloba leaf extractcao lá bạch quả
02

Targets

PTAFR (Platelet-activating factor receptor)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)

Beyond the preview

Go deeper on Vasoclean.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vasoclean.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call